ERBB3 and cancer: Indeed, treatment of EGFR-positive cancer cells with CL4 strongly inhibits both the EGF-induced tyrosine phosphorylation of EGFR and ErbB2 and the Hrg-dependent tyrosine phosphorylation of EGFR and ErbB3.